Subscribe To
Editas Medicine Announces Second Quarter 2023 Results Conference Call and Corporate Update
CAMBRIDGE, Mass., July 26, 2023 (GLOBE NEWSWIRE) — Editas Medicine, Inc. (Nasdaq: EDIT), a clinical-stage genome editing company, today announced that it will host a conference call and webcast on Wednesday, August 2, 2023, at 8:00 a.m. ET to discuss results for the second quarter 2023 and to provide a corporate update. To access the conference call: U.S. […] The post Editas Medicine Announces Second Quarter 2023 Results Conference Call and Corporate Update appeared first on ForexTV...
Read More
Posted: Jul 26 2023, 11:00
Author Name: forextv
Views: 080831